NCT05424250

Brief Summary

The effectiveness of an optimized extinction training is investigated in spider-fearful individuals. Participants will undergo a one-session standardized extinction training, either with or without occasional metal imagination of most feared apprehension towards spiders. The effectiveness of the training is measured by symptom improvement according to subjective ratings and behavioural avoidance tests one week later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

June 15, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

June 14, 2022

Last Update Submit

January 7, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Spider Phobia Questionnaire (SPQ)

    31-item true/false questionnaire assessing symptoms of arachnophobia. Scores range from 0 to 31, with greater scores representing greater fear of spiders. Spider phobic individuals have obtained mean scores of 23.20 (SD = 2.90) and 23.76 (SD = 3.80) on the SPQ.

    Change from baseline to post-treatment (i.e., 7-9 days)

  • Behavioral Approach Test (BAT)

    Number of test steps fully completed (0-14 steps)

    Change from baseline to post-treatment (i.e., 7-9 days)

  • Fear rating

    Maximum fear rating on a scale from 0 (no fear) to 100 (severe fear) recorded once during BAT

    Change from baseline to post-treatment (i.e., 7-9 days)

Secondary Outcomes (4)

  • Fear of Spider Questionnaire (FSQ)

    Change from baseline to post-treatment (i.e., 7-9 days)

  • Change in anxiety sensitivity (ASI-3)

    change from baseline to post-treatment (i.e. 7-9 days)

  • PROMIS Emotional Distress-Anxiety-Short Form

    change from baseline to post-treatment (i.e. 7-9 days)

  • US expectancy and fear ratings

    Baseline

Study Arms (2)

Exposure + occasional aversive imagination

EXPERIMENTAL

repeated imaginations of the participants' most feared apprehension during extinction training with seven standardized exposure steps

Behavioral: occasional aversive imaginationBehavioral: Exposure

Exposure

ACTIVE COMPARATOR

Standard extinction training with seven standardized exposure steps

Behavioral: Exposure

Interventions

During six of the 27 exposure trials, participants in the experimental group are asked to imagine their most feared outcome towards spiders as vividly as possible while completing the specific trial.

Exposure + occasional aversive imagination
ExposureBEHAVIORAL

• All participants complete an exposure training session (approx. 75 min) with seven exposure steps, which are repeated between one and five times (e.g. Step 4: directing the spider with a pen by touching its legs at least five times per repetition; this step must be repeated five times before continuing to the next step). One repetition per step is considered one trial, therefore each participant aims to complete 27 exposure trials.

ExposureExposure + occasional aversive imagination

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elevated score on Spider Phobia Questionnaire (SPQ) \> 17

You may not qualify if:

  • Severe allergies to bees/spiders/insects
  • current psychotherapeutic/psychiatric treatment
  • past psychotherapeutic/psychiatric treatment due to anxiety problems
  • current or past psychotic symptoms
  • current suicidal intent
  • experience with exposure-based treatment
  • current psychopharmacological medication
  • severe cardiovascular, respiratory or neurological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Philipps-University Marburg

Marburg, Hesse, 35037, Germany

Location

Related Publications (5)

  • Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014 Jul;58:10-23. doi: 10.1016/j.brat.2014.04.006. Epub 2014 May 9.

    PMID: 24864005BACKGROUND
  • Culver NC, Stevens S, Fanselow MS, Craske MG. Building physiological toughness: Some aversive events during extinction may attenuate return of fear. J Behav Ther Exp Psychiatry. 2018 Mar;58:18-28. doi: 10.1016/j.jbtep.2017.07.003. Epub 2017 Jul 25.

    PMID: 28777975BACKGROUND
  • Lipp OV, Ryan KM, Luck CC, Craske MG, Waters AM. Presentation of unpaired unconditional stimuli during extinction reduces renewal of conditional fear and slows re-acquisition. Psychophysiology. 2021 Oct;58(10):e13899. doi: 10.1111/psyp.13899. Epub 2021 Jul 6.

    PMID: 34231228BACKGROUND
  • Shiban Y, Wittmann J, Weissinger M, Muhlberger A. Gradual extinction reduces reinstatement. Front Behav Neurosci. 2015 Sep 15;9:254. doi: 10.3389/fnbeh.2015.00254. eCollection 2015.

    PMID: 26441581BACKGROUND
  • Thompson A, McEvoy PM, Lipp OV. Enhancing extinction learning: Occasional presentations of the unconditioned stimulus during extinction eliminate spontaneous recovery, but not necessarily reacquisition of fear. Behav Res Ther. 2018 Sep;108:29-39. doi: 10.1016/j.brat.2018.07.001. Epub 2018 Jul 3.

    PMID: 29981936BACKGROUND

MeSH Terms

Conditions

Arachnophobia

Study Officials

  • Christoph Benke, PhD

    Philipps University Marburg

    PRINCIPAL INVESTIGATOR
  • Christiane Pané-Farré, PhD

    Philipps University Marburg

    PRINCIPAL INVESTIGATOR
  • Dorothee Scheuermann, M.Sc.

    Philipps University Marburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 14, 2022

First Posted

June 21, 2022

Study Start

June 15, 2022

Primary Completion

July 31, 2023

Study Completion

September 30, 2023

Last Updated

January 9, 2026

Record last verified: 2026-01

Locations